Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2798745 LPS Challenge in Healthy Participants
NCT03511105Phase 1Terminated
- Sponsor
- GSK
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in acute respiratory distress syndrome (ARDS) comparing GSK2798745 with Placebo (2 arms). Primary endpoint: Baseline Adjusted Total Protein Concentration in Broncho-alveolar (BAL) Samples. Started Jun 2018; status: terminated.
02
Drugs
GSK2798745
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT03511105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03511105.